Optimal processing of bone marrow trephine biopsy: The Hammersmith Protocol

Ealing, Hammersmith & West London College, Londinium, England, United Kingdom
Journal of Clinical Pathology (Impact Factor: 2.92). 10/2006; 59(9):903-11. DOI: 10.1136/jcp.2004.020610
Source: PubMed


Specimens of bone marrow trephine biopsy (BMT) are transported and fixed in acetic acid-zinc-formalin fixative, decalcified in 10% formic acid-5% formaldehyde and processed with other specimens to paraffin-wax embedding. Sections, 1-microm-thick, are cut by experienced histotechnologists and used for haematoxylin and eosin, Giemsa, reticulin silver and other histological stains. Further, all immunohistochemical procedures used in the laboratory, including double immunostaining, can be used on these sections with no or minimal modifications. About 10,000 BMT specimens have been analysed using this procedure since 1997 and diseases involving the bone marrow have been classified successfully. More recently, standardised polymerase chain reaction-based analysis and mRNA in situ hybridisation studies have been conducted. Excellent morphology with good antigen, DNA and RNA preservation is offered by the Hammersmith Protocol.

Download full-text


Available from: Donna Horncastle
  • [Show abstract] [Hide abstract]
    ABSTRACT: Follicular lymphomas (FL) are frequent B-cell-derived malignancies, generally demonstrating an indolent evolution. Peripheral blood and bone marrow involvement by FL cells is infrequent. The aim of this study was to evaluate morphological features including immunophenotypic analysis of leukaemic follicular lymphoma on flow cytometry. The present study included 13 cases diagnosed on flow cytometry as follicular lymphoma involving peripheral blood or bone marrow over a period of 2 years (May 2010 to May 2012). Clinical presentation, complete blood count, peripheral smear, bone marrow aspirate and biopsy, lymph node biopsy and immunophenotypic profile by flow cytometric analysis of cases were reviewed. We observed in 13 patients a leukaemic phase of FL at the onset of the disease. Twelve of them had concomitant lymph node involvement whereas one patient had pure follicular cell leukaemia. In seven of 13 cases, there was absence of CD10 on flow cytometric analysis of circulating cells. Out of these seven cases, a lymph node biopsy was done in six cases, and all six cases showed CD10-positive neoplastic germinal centres.
    No preview · Article · Jun 2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute myeloid leukaemia (AML) with multilineage dysplasia (MD) is one of the four main categories of AML in the World Health Organization (WHO) classification. The role of bone marrow trephine biopsy (BMTB) histology and immunohistochemistry in the diagnosis of AML-MD is currently unclear. BMTBs were studied in 11 cases of AML-MD and two cases of myelodysplasia that subsequently transformed to AML. Among them, six cases showed trilineage dysplasia and seven showed bilineage dysplasia. With respect to conforming to the WHO definition of AML, documentation of an increased proportion of immature myeloid cells was possible on morphology and counting of immature cells following immunostaining with CD34, CD117 or HLA-DR antibodies. Recognition and quantification of dysplastic features in the haemopoietic lineages was made easier by immunohistochemistry with antibodies to ret40f (glycophorin C), myeloperoxidase, CD61 and/or CD42b, CD34, CD117 and HLA-DR. Based on this relatively small series of cases we show the utility of BMTB and immunohistochemistry as an aid to the diagnosis of AML-MD. This has to be seen not just in light of its utility at diagnosis, but also the role the diagnostic BMTB would play for purposes of comparison when follow-up BMTBs are submitted in this group of patients.
    Preview · Article · Mar 2008 · British Journal of Haematology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Multiple myeloma (MM) guidelines in the UK do not advocate performing bone marrow trephine biopsy (BMTB) during follow-up. In a recent study, it was found that the plasma cell per cent (PC%) in BMTB performed at the time of autologous stem cell transplant strongly correlated with survival. The current study addresses whether BMTB is superior to bone marrow aspiration (BMA) in documenting presence of disease and its volume at follow-up. The study involved 106 samples. A conventional 500-cell differential count was performed on the BMAs to document the PC%. The PC% on BMTBs had been estimated on CD138 immunostain. Furthermore, BMTBs had also been immunostained for CD56, cyclin D1 and light chains. The mean (2SEM) PC% values in BMAs and BMTBs were 13.1 (2.6)% and 31.8 (5.8)% respectively. Based on BMA, BMTB and serum/urine paraprotein or light chain estimation, on 92 occasions (89%) there was detectable disease. The positive predictive value of both BMA and BMTB was 100%, and the negative predictive values for BMTB and BMA were 57% and 22% respectively. Among 98 secretory MM cases, the BMTB-PC% showed significant correlation with paraprotein levels, whereas BMA-PC% did not. It is strongly recommended that BMTB is performed and adequately investigated with immunohistochemistry during follow-up of MM.
    No preview · Article · Mar 2008 · Journal of clinical pathology
Show more